The hemocompatibility of oxidized diamond nanocrystals for biomedical applications

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Li, Hung Cheng ^a   Hsieh, Feng Jen ^a   Chen, Ching Pin ^b   Chang, Ming Yao ^b   Hsieh, Patrick C H ^b,c   Chen, Chia Chun ^d   Hung, Shain Un ^e   Wu, Che Chih ^e   Chang, Huan Cheng ^a  

^a INSTITUTE OF ATOMIC AND MOLECULAR SCIENCES   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^e NATIONAL CHI NAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BIOMATERIAL; DIAMOND; HEPARIN; NANOCONJUGATE; NANOPARTICLE;

ANIMAL; CELL SURVIVAL; CHEMISTRY; DIAGNOSTIC USE; HEMOLYSIS; HUMAN; MATERIALS TESTING; MOUSE; NANOMEDICINE; PARTIAL THROMBOPLASTIN TIME; PARTICLE SIZE; PROCEDURES; ULTRASTRUCTURE;

ANIMALS; ANTICOAGULANTS; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; DIAMOND; HEMOLYSIS; HEPARIN; HUMANS; MATERIALS TESTING; MICE; NANOCONJUGATES; NANOMEDICINE; NANOPARTICLES; PARTIAL THROMBOPLASTIN TIME; PARTICLE SIZE;

EID: 84928524824     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03044     Document Type: Article

References (55)

1. Bianco, A., Kostarelos, K. & Prato, M. Opportunities and challenges of carbonbased nanomaterials for cancer therapy. Expert Opin. Drug Deliv. 5, 331-342 (2008)
2. Cha, C., Shin, S. R., Annabi, N., Dokmeci, M. R. & Khademhosseini, A. Carbonbased nanomaterials: Multifunctional materials for biomedical engineering. ACS Nano 7, 2891-2897 (2013)
3. Fiorito, S., Serafino, A., Andreola, F., Togna, A. & Togna, G. Toxicity and biocompatibility of carbon nanoparticles. J. Nanosci. Nanotechnol. 6, 591-599 (2006)
4. Schrand, A. M. et al. [Cytotoxicity and genotoxicity of carbon nanomaterials] Safety of Nanoparticles, Nanostructure Science and Technology [Webster, T. J. (ed.)] 159-187 (Springer: New York, 2009)
5. Kolosnjaj, J., Szwarc, H. & Moussa, F. Toxicity studies of carbon nanotubes. Adv. Exp. Med. Biol. 620, 181-204 (2007)
6. Fisher, C. et al. Applications and nanotoxicity of carbon nanotubes and graphene in biomedicine. J. Nanomater. 2012, 315185 (2012)
7. Feng, L. & Liu, Z. Graphene in biomedicine: Opportunities and challenges. Nanomedicine 6, 317-324 (2011)
8. Wang, K. et al. Biocompatibility of graphene oxide. Nanoscale Res. Lett. 6, 8 (2011)
9. Hu, W. et al. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 5, 3693-3700 (2011)
10. Liao, K.-H., Lin, Y.-S., Macosko, C. W. & Haynes, C. L. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl. Mater. Interfaces 3, 2607-2615 (2011)
11. Singh, S. K. et al. Thrombus inducing property of atomically thin graphene oxide sheets. ACS Nano 5, 4987-4996 (2011)
12. Sasidharan, A. et al.Hemocompatibility and macrophage response of pristine and functionalized graphene. Small 8, 1251-1263 (2012)
13. Chen, G.-Y. et al. Simultaneous induction of autophagy and toll-like receptor signaling pathways by graphene oxide. Biomaterials 33, 6559-6569 (2012)
14. Yue, H. et al. The role of the lateral dimension of graphene oxide in the regulation of cellular responses. Biomaterials 33, 4013-4021 (2012)
15. Cheng, C. et al. Biopolymer functionalized reduced graphene oxide with enhanced biocompatibility via mussel inspired coatings/anchors. J. Mater. Chem. B 1, 265-275 (2013)
16. Schranda, A. M., Dai, L., Schlager, J. J., Hussain, S. M. & Osawa, E. Differential biocompatibility of carbon nanotubes and nanodiamonds. Diam. Relat. Mater. 16, 2118-2123 (2007)
17. Zhang, X., Hu, W., Li, J., Tao, L. &Wei, Y. A comparative study of cellular uptake and cytotoxicity of multi-walled carbon nanotubes, graphene oxide, and nanodiamond. Toxicol. Res. 1, 62-68 (2012)
18. Mochalin, V. N., Shenderova, O., Ho, D. & Gogotsi, Y. The properties and applications of nanodiamonds. Nat. Nanotechnol. 7, 11-23 (2012)
19. Evani, S. J. & Ramasubramanian, A. K. Hemocompatibility of nanoparticles, in Nanobiomaterials Handbook Sitharaman, B. (ed.) CRC Press, 2011, Chap. 31
20. Liu, K.-K. et al. Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy. Nanotechnology 21, 315106 (2010)
21. Chow, E. K. et al. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Sci. Transl. Med. 3, 73ra21 (2011)
22. Trpkovic, A. et al. Oxidative stress-mediated hemolytic activity of solvent exchange-prepared fullerene (C60) nanoparticles. Nanotechnology 21, 375102 (2010)
23. Radomski, A. et al. Nanoparticle-induced platelet aggregation and vascular thrombosis. Brit. J. Pharmacol. 146, 882-893 (2005)
24. Burke, A. R. et al. Determinants of the thrombogenic potential of multiwalled carbon nanotubes. Biomaterials 32, 5970-5978 (2011)
25. Lacerda, S. H. et al. Carbon nanotubes activate store-operated calcium entry in human blood platelets. ACS Nano 5, 5808-5813 (2011)
26. Puzyr, A. P. et al. Destruction of human blood cells in interaction with detonation nanodiamonds in experiments in vitro. Diam. Relat. Mater. 13, 2020-2023 (2004)
27. Kumari, S., Singh, M. K., Singh, S. K., Grácio, J. J. & Dash, D. Nanodiamonds activate blood platelets and induce thromboembolism. Nanomedicine DOI:10.2217/NNM.13.23 (2013)
28. Lin, Y.-C. et al. The influence of nanodiamond on the oxygenation states and micro-rheological properties of human red blood cells in vitro. J. Biomed. Opt. 17, 101512 (2012)
29. Björk, I. & Lindahl, U. Mechanism of the anticoagulant action of heparin. Mol. Cell. Biochem. 48, 161-182 (1982)
30. Chong, B. H. Heparin-induced thrombocytopenia. J. Thromb. Haemost. 1, 1471-1478 (2003)
31. Gutowska, A., Bae, Y. H., Feijen, J. & Kim, S. W. Heparin release from thermosensitive hydrogels. J. Control. Release 22, 95-104 (1992)
32. Ahola, M. S. et al. In vitro release of heparin from silica xerogels. Biomaterials 22, 2163-2170 (2001)
33. Park, T.-J. et al. Preparation and characterization of heparinized multi-walled carbon nanotubes. Process Biochem. 47, 113-118 (2012)
34. Tang, A. C. L. et al. Treatment of acute thromboembolism in mice using heparinconjugated carbon nanocapsules. ACS Nano 6, 6099-6107 (2012)
35. Tang, A. C. et al. Biosafety of non-surface modified carbon nanocapsules as a potential alternative to carbon nanotubes for drug delivery purposes. PLoS One 7, e32893 (2012)
36. Huang, L. C. L. & Chang, H.-C. Adsorption and immobilization of cytochrome c on nanodiamonds. Langmuir 20, 5879-5884 (2004)
37. Nguyen, T. T.-B., Chang, H.-C. & Wu, V. W.-K. Adsorption and hydrolytic activity of lysozyme on diamond nanocrystallites. Diamond Relat. Mater. 16, 872-876 (2007)
38. Chang, C.-K., Wu, C.-C., Wang, Y.-S. & Chang, H.-C. Selective extraction and enrichment of multi-phosphorylated peptides using polyarginine-coated diamond nanoparticles. Anal. Chem. 80, 3791-3797 (2008)
39. Hsieh, C.-C. et al. Quantitative analysis of oligosaccharides derived from sulfated glycosaminoglycans by nanodiamond-based affinity purification and MALDI MS. Anal. Chem. 85, 4342-4349 (2013)
40. Vial, S. et al. Peptide-grafted nanodiamonds: Preparation, cytotoxicity and uptake in cells. Chembiochem. 9, 2113-2119 (2008)
41. Belgacem, O. et al. Molecular mass determination of plasma-derived glycoproteins by ultraviolet matrix-assisted laser desorption/ionization time-offlight mass spectrometry with internal calibration. J. Mass Spectrom. 37, 1118-1130 (2002)
42. Dobrovolskaia, M. A. et al. Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett. 8, 2180-2187 (2008)
43. Slowing, I. I., Wu, C.-W., Vivero-Escoto, J. L. & Lin, V. S. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 5, 57262 (2009)
44. Lin, Y.-S. & Haynes, C. L. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J. Am. Chem. Soc. 132, 483424842 (2010)
45. Yildirim, A., Ozgur, E. & Bayindir, M. Impact of mesoporous silica nanoparticle surface functionality on hemolytic activity, thrombogenicity and non-specific protein adsorption. J. Mater. Chem. B 1, 1909-1920 (2013)
46. Bjornsson, T. D. & Gerhard, L. Pharmacokinetics of heparin. I. Studies of dose dependence in rats. J. Pharmacol. Exp. Ther. 210, 237-242 (1979)
47. Bjornsson, T. D. & Gerhard, L. Pharmacokinetics of heparin. II. Studies of time dependence in rats. J. Pharmacol. Exp. Ther. 210, 243-246 (1979)
48. Passirani, C., Barratt, G., Devissaguet, J.-P. & Labarre, D. Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). Pharm. Res. 15, 1046-1050 (1998)
49. Raetz, C.&Whitfield, C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 6352700 (2002)
50. Kong, X. L. et al. High-affinity capture of proteins by diamond nanoparticles for mass spectrometric analysis. Anal. Chem. 77, 259-265 (2005)
51. Chen, W.-H. et al. Solid phase extraction and elution on diamond (SPEED): A fast and general platform for proteome analysis with mass spectrometry. Anal. Chem. 78, 4228-4234 (2006)
52. Lim, J. K., Majetich, S. A. & Tilton, R. D. Stabilization of superparamagnetic iron oxide core - gold shell nanoparticles in high ionic strength media. Langmuir 25, 13384-13393 (2009)
53. Tzeng, Y.-K. et al. Superresolution imaging of albumin-conjugated fluorescent nanodiamonds in cells by stimulated emission depletion. Angew. Chem. Int. Ed. 50, 2262-2265 (2011)
54. Yuan, Y., Chen, Y., Liu, J. H., Wang, H. & Liu, Y. Biodistribution and fate of nanodiamonds in vivo. Diam. Relat. Mater. 18, 95-100 (2009)
55. Wang, D.-Y. et al. Quantum dot light-emitting diode using solution-processable graphene oxide as the anode interfacial layer. J. Phys. Chem. C 116, 10181-10185 (2012)